Concepedia

Antonio Cusmai

AC

8

Publications

449

Citations

8

H-Index

2001

Active since

Affiliations

Istituto Tumori Bari(Current)

University of Bari Aldo Moro

Fondazione IRCCS Istituto Nazionale dei Tumori

University of Modena and Reggio Emilia

Istituti di Ricovero e Cura a Carattere Scientifico

Antonio Cusmai is an author at Istituto Tumori Bari specializing in medicine, radiation oncology, and pharmacotherapy.

ORCID

Top concepts

Publications per year

2001–2022

8

Publications

8

Autocrine interleukin-6 production and highly malignant multiple myeloma: relation with resistance to drug-induced apoptosis

Maria Antonia Frassanito, Antonio Cusmai, Giuseppe Iodice et al. · Blood · 2001 · 158 citations · Full text

Which role for predictors of response to immune checkpoint inhibitors in hepatocellular carcinoma?

Alessandro Rizzo, Antonio Cusmai, Gennaro Gadaleta‐Caldarola et al. · Expert Review of Gastroenterology & Hepatology · 2022 · 87 citations

Deregulated cytokine network and defective Th1 immune response in multiple myeloma

Maria Antonia Frassanito, Antonio Cusmai, Franco Dammacco · Clinical & Experimental Immunology · 2001 · 83 citations · Full text

, , +18

A multicenter phase 2 single arm study of cabozantinib in patients with advanced or unresectable renal cell carcinoma pre-treated with one immune-checkpoint inhibitor: The BREAKPOINT trial (Meet-Uro trial 03)

Giuseppe Procopio, Mélanie Claps, Chiara Pircher et al. · Tumori Journal · 2022 · 46 citations · Full text

Manumycin inhibits farnesyltransferase and induces apoptosis of drug‐resistant interleukin 6‐producing myeloma cells

Maria Antonia Frassanito, Antonio Cusmai, Cláudia Piccoli et al. · British Journal of Haematology · 2002 · 32 citations

Rows per page

1–5 of 8